SecBot SecBot
SECBOTREPLAY Home › Report › ELAN

ELAN · Q3 revenue +11% YoY

Elanco Animal Health Inc · 8-K filed Nov 6, 2026 at 06:27 ET

At the news

BULLISHIMPACT 6/10

8-K filed Nov 6, 2026 at 06:27 ET

Elanco reported Q3 2026 revenue of $1.265B (+11% YoY, +9% organic constant currency) and adjusted EPS of $0.27, beating consensus of $0.20. The company raised full-year 2026 revenue guidance to $5.155B-$5.18B, adjusted EBITDA to $1.05B-$1.065B, and adjusted EPS to $1.17-$1.20, all above prior ranges. Adjusted gross margin expanded 300 bps YoY to 56.1%, and net leverage improved to 2.9x, unlocking capital allocation flexibility.

  • Q3 2026 revenue $1.265B, +11% YoY reported, +9% organic constant currency
  • Adjusted EPS $0.27 vs consensus $0.20, a 35% beat
  • Full-year 2026 revenue guidance raised to $5.155B-$5.18B (from $5.09B-$5.14B)
  • Full-year 2026 adjusted EPS guidance raised to $1.17-$1.20 (from $1.10-$1.16)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access